Skip to content

Invited Lectures

Event Timeslots (8)

Wednesday, June 15
-

Lipid nanoparticles for cancer immunotherapy

Shyh-Dar (Star) Li (UBC | NMIN)

Enhancing T cell functionality with nanotechnology in adoptive cell therapy

Thomas L. Andresen (Technical University of Denmark)


mbeck

Monday, June 13
-

Lipid-based nanopreparations for stimuli-sensitive and organelle-specific targeting

Vladimir Torchilin (Northeastern U)

Multifunctional Envelope-type Nano Device from Controlled Intracellular Trafficking to Clinical Application for Nanomedicines

Hideyoshi Harashima (U Sapporo)

Polymer/oil-based nanocapsules vs. LNPs as RNA delivery vehicles

Maria Jose Alonso (U Santiago de Compostela )


mbeck

Tuesday, June 14
-

RNA and lipid nanoparticles for controlling bleeding and thrombosis

Christian Kastrup (Medical College of Wisconsin)

Overcoming the barrier - Topical gene therapy of skin and lung

Sarah Hedtrich (UBC)

Optimizing lipid nanoparticles for in vivo therapeutic genome editing

Colin Ross (UBC)


mbeck

Wednesday, June 15
-

The PEG-mediated accelerated blood clearance effect in mRNA-LNP evoked T-cell immunity

Ray Schiffelers (University Medical Center Utrecht)

Porphyrin-lipid nanoparticles: building intrinsic multifunction into LNP

Gang Zheng (U Toronto)

Lipids, Polymers and Other LNP Components: How can they work together?

Yvonne Perrie (U Strathclyde)


mbeck

Monday, June 13
-

On the mechanism of tissue-specific mRNA delivery by selective organ targeting (SORT) lipid nanoparticles (LNPs)

Dan Siegwart (UT Southwestern)

Boosting intracellular delivery of mRNA therapeutics & its applications

Gaurav Sahay (Oregon State U)

Development of broadly protective influenza vaccines using nucleoside-modified mRNA

Norbert Pardi (U Penn)


mbeck

Wednesday, June 15
-

Liposomal Antibiotics Induce Anticancer Immunity by Killing the Tumor-Associated Bacteria

Leaf Huang (U North Carolina)

The effect of sex & the tumor microenvironment on liposomal cancer treatments

Avi Schroeder (Israel Institute of Technology)

On the structural characterisation of lipid nanoparticle formulations of nucleic acid

Jay Kulkarni (NanoVation)


mbeck

Tuesday, June 14
-

Liposomal Hydroxychloroquine-An example of what can happen to a liposomologist during the COVID pandemic

Marcel Bally (UBC|NMIN)

Therapeutics based on liposomal drug targeting to well-accessible organs

Gert Storm (Utrecht University)


mbeck

Monday, June 13
-

Army Liposome formulation with QS21 (ALFQ): A potent & safe vaccine adjuvant

Carl Alving (Walter Reed Army Institute of Research)

Optimization of Lipid Nanoparticles for Self-Amplifying RNA Expression & Cellular Activation Using a Design-of-Experiment Approach

Anna Blakney (UBC|NMIN)

LNP formulated saRNA – learning from clinical experience

Robin Shattock (Imperial College London)

The development of effective medicinal products in Africa by Africa for Africans

Anne Grobler (North-West University)


mbeck